CD4 and tuberculosis: Overall, 61 patients (78.2%) presented at an advanced disease stage (CD4+ cell count < 200 cells/L), 66 patients (84.6%) developed the disease within 90 days of enrolment, and 31 patients (39.7%) had extrapulmonary TB.